abagovomab 23
abciximab 24
abituzumab 21
abrilumab 18
actoxumab 13
adalimumab 17
aducanumab 8
afasevikumab 14
alacizumab_pegol 11
alemtuzumab 20
alirocumab 15
amatuximab 30
andecaliximab 17
anifrolumab 18
anrukinzumab 16
aprutumab 13
aprutumab_ixadotin 13
arcitumomab 17
ascrinvacumab 4
atezolizumab 16
atinumab 15
avelumab 12
basiliximab 23
bavituximab 29
begelomab 17
benralizumab 20
bevacizumab_beta 19
bezlotoxumab 13
bimagrumab 10
bleselumab 12
blinatumomab 25
blosozumab 27
bococizumab 15
brazikumab 14
brentuximab_vedotin 26
briakinumab 15
brodalumab 7
brolucizumab 25
brontictuzumab 21
burosumab 17
cabiralizumab 24
camrelizumab 10
canakinumab 20
cantuzumab_ravtansin 36
carlumab 12
carotuximab 24
cergutuzumab_amunaleukin2 23
cergutuzumab_amunaleukin 23
certolizumab_pegol 25
cetiximab 38
citatuzumab_bogatox 25
cixutumumab 21
clivatuzumab_tetraxetan 14
codrituzumab 28
conatumumab 9
concizumab 28
crenezumab 18
crizanlizumab 25
crotedumab 20
dacetuzumab 21
daclizumab 10
dalotuzumab 29
dapirolizumab_pegol 22
daratumumab 13
dectrekumab 8
demcizumab 20
denosumab 8
depatuxizumab 20
depatuxizumab_mafodotin 20
dezamizumab 13
dinutuximab 29
diridavumab 16
domagrozumab 13
drozitumab 12
duligotuzumab 19
durvalumab 7
dusigitumab 10
efalizumab 30
efungumab 26
eldelumab 13
elezanumab 18
elgemtumab 11
elotuzumab 11
emactuzumab 15
emapalumab 25
emibetuzumab 14
enavatuzumab 23
enfortumab_vedotin 12
enoblituzumab 15
enokizumab 22
enoticumab 15
ensituximab 23
eptinezumab 15
erenumab 15
etaracizumab 15
etrolizumab 22
evinacumab 20
evolocumab 11
farletuzumab 3
fasinumab 19
fezakinumab 15
fibatuzumab 8
ficlatuzumab 18
firivumab 27
flanvotumab 15
fletikumab 14
foralumab 9
foravirumab 13
fremanezumab 27
fresolimumab 16
fulranumab 18
futuximab 18
galcanezumab 16
ganitumab 20
gantenerumab 10
gemetuzumab 21
gemtuzumab2 24
gemtuzumab 19
gevokizumab 21
girentuximab 27
glembatumumab 15
glembatumumab_vedotin 15
guselkumab 19
ibalizumab 21
ibritumomab 22
icrucumab 8
idarucizumab 28
ifabotuzumab 8
imalumab 16
imgatuzumab 16
inclacumab 17
indatuximab_ravtansin 22
indusatumab 11
inebilizumab 22
intetumumab 10
iodine_girentuximab 27
ipilimumab 3
iratumumab 6
isatuximab 26
itolizumab 22
ixekizumab 29
labetuzumab_govitecan 18
lambrolizumab 23
lampalizumab 20
lanadelumab 18
landogrozumab 18
laprituximab 21
lebrikizumab 32
lendalizumab 22
lenzilumab 15
lifastuzumab_vedotin 24
ligelizumab 20
lilotomab 29
lirilumab 21
lodelcizumab 16
lokivetmab 22
lorvotuzumab_mertansin 20
lucatumumab 27
lumretuzumab 14
lupartumab 12
lutikizumab 18
margetuximab 27
milatuzumab 36
mirvetuximab 21
mirvetuximab_soravtansin 21
modotuximab 31
mogamulizumab 28
monalizumab 16
motavizumab 30
moxetumomab_pasudotox 22
namilumab 16
naratuximab 23
naratuximab_emtansin 23
narnatumab 14
navicixizumab2 24
navicixizumab 22
navivumab 30
necitumumab 9
nemolizumab 21
nesvacumab 13
nivolumab 11
obiltoxaximab 19
obinutuzumab 30
ocaratuzumab 20
ofatumumab 18
olaratumab 18
olokizumab 23
omalizumab 19
onartuzumab 20
ontuxizumab 21
opicinumab 13
orticumab 13
otelixizumab 34
oxelumab 12
ozanezumab 29
pamrevlumab 11
panobacumab 23
parsatuzumab 24
pasotuxizumab 22
pateclizumab 14
patritumab 14
pembrolizumab 23
perakizumab 21
pidilizumab 14
pinatuzumab_vedotin 19
plozalizumab 26
pogalizumab 20
polatuzumab_vedotin 22
ponezumab 31
prezalumab 13
pritoxaximab 23
quilizumab 19
racotumomab 25
radretumab 13
ralpancizumab 20
ramucirumab 13
ranevetmab 24
ranibizumab 19
refanezumab 21
remtolumab 17
rilotumumab 12
rinucumab 14
risankizumab 29
rituximab 16
rivabazumab 13
robatumumab 20
roledumab 25
romosozumab 17
rontalizumab 19
rosmantuzumab 20
rozanolixizumab 20
sacituzumab 22
sacituzumab_govitecan 22
samalizumab 22
sapelizumab 22
sarilumab 15
secukinumab 11
seribantumab 16
setoxaximab 35
sifalimumab 8
siltuximab 17
simtuzumab 23
sirukumab 12
solanezumab 26
solitomab 19
stamulumab 16
suptavumab 19
suvizumab 17
tabalumab 9
tadocizumab 11
tamtuvetmab 28
tanezumab 19
tarextumab 10
tavolixizumab 13
telisotuzumab 24
teplizumab 16
tesidolumab 18
tezepelumab 22
tigatuzumab 15
tildrakizumab 19
timolumab 12
tisotumab 8
tosatoxumab 26
tositumomab 22
tralokinumab 21
trastuzumab 21
tregalizumab 21
trevogrumab 11
ublituximab 26
urelumab 15
ustekinumab 24
utomilumab 26
vadastuximab 20
vadastuximab_talirin 20
vandortuzumab_vedotin 14
vantictumab 18
vanucizumab2 19
vanucizumab 26
varlilumab 13
vatelizumab 17
vedolizumab 21
veltuzumab 10
vesencumab 10
vorsetuzumab 18
vorsetuzumab_mafodotin 18
vunakizumab 26
xentuzumab 15
zatuximab 31
